Endoscopic submucosal dissection is safe for selected colorectal cancer patients.

In a review of 1,398 patients undergoing endoscopic submucosal dissection for early-stage colorectal cancer, findings indicated that 14% exhibited lymph node metastasis post-oncologic colon resection. Significant predictors for metastasis included a submucosal invasion depth of ≥2.00 mm, correlating with an 18.7 odds ratio. Conversely, lesions exceeding 20 mm in diameter had a lower likelihood of metastasis. The study supports endoscopic dissection as a viable treatment for selected early-stage colorectal cancer patients.

Journal Article by Ulkucu A, Erkaya M (…) Gorgun E et 6 al. in BMC Surg

Published by Elsevier Inc.

read the whole article in BMC Surg

open it in PubMed